Perrigo seeks approval for generic Zegerid OTC, Schering-Plough files suit
ALLEGAN, Mich. Perrigo has filed for regulatory approval of a generic version of an over-the-counter medication for frequent heartburn, prompting a lawsuit from the branded version’s manufacturer.
The company announced Friday that it had filed for approval for omeprazole and sodium bicarbonate in the 20 mg/1,100 mg strength. The medication is a generic version of Zegerid OTC, made by Schering-Plough HealthCare, a subsidiary of Merck.
Schering-Plough filed a lawsuit Monday alleging patent infringement in the U.S. District Court for the District of New Jersey to prevent Perrigo’s commercialization of the product.
Zegerid had sales of around $60 million during the 12-month period ended in the “most recent month,” according to SymphonyIRI Group.
Fresh & Easy develops line for kids
SAN DIEGO Fresh & Easy is promoting its new line of products aimed at childhood nutrition.
The line, fresh&easy Goodness, is made using such wholesome, natural foods as whole grains, fruits and vegetables, as well as other foods that are good sources of vitamins and minerals. Fresh&easy Goodness products also contain no artificial colors, flavors or preservatives, no added trans fats and no high-fructose corn syrup.
"We fundamentally believe every family deserves access to fresh, wholesome food at affordable prices," said Fresh & Easy CEO Tim Mason. "Everything we do derives from listening to our customers, and one thing we’ve heard consistently from parents is that they are looking for ways to feed their children high-quality, nutritious foods without stretching their budgets. Fresh&easy Goodness for kids offers an affordable and convenient solution for busy parents that won’t break the bank."
NCPA supports drug disposal bills, makes approval recommendations
ALEXANDRIA, Va. A group representing the nation’s independent pharmacies heralded two pieces of legislation that pertain to the safe disposal of prescription drugs.
The National Community Pharmacists Association announced its support of legislative efforts made by the House of Representatives and the Senate, which passed their respective drug disposal bills Wednesday and last month. NCPA also added that it was “a giant step forward to allow for controlled substances, which had previously been precluded from any disposal programs, to be included.”
The lobbying group did, however, express concern that neither bill passed by the legislative bodies will provide liability protections for participating pharmacies nor adequate funding mechanisms or grant programs to assist in the cost of responsible collection. These concerns were conveyed to the House prior to the vote, NCPA said.
“Independent community pharmacists are uniquely positioned to help Americans get rid of expired and unused prescription drugs,” said Joseph Harmison, NCPA president and pharmacy owner. “That’s why over 1,000 member pharmacies are now engaged in a successful drug disposal programs with Sharps Compliance Inc.”